Innovation

Mouse H2-M3 MHC Class Ib Monoclonal Antibody

University of Chicago
posted on 08/18/2009

Hybridoma mAb 130 (Murine H2-M3 MHC Class Ib) UCHI 0838   Antigen: Mouse H2-M3 MHC Class Ib   Antigen Background: H2-M3 MHC class Ib is a non-classical MHC class I molecule that is specialized for binding N -formyl peptides.  N -formyl peptides are produced by prokaryotes during protein synthesis, but are rare in mammalian cells.  H2-M3 restricted CD8+ T-cells are early responders during primary infections, appearing 1-2 days earlier than MHC class Ia restricted memory CTLs.  H2-M3 plays a significant role in responding to bacterial infections and appears to be important in bridging the innate and adaptive immune responses.   Antibody Class: Hamster IgG   H2-M3 species recognized: Mouse   Hybridoma Production: The soluble portion of H2-M3 was purified from D. melanogaster cell line SC2 and used to immunize Armenian hamsters.  Lymphocytes isolated from immunized hamsters were used to produce hybridoma cell lines by fusion with murine myeloma cell line SP2/0.  Hybridoma supernatants were screened for H2-M3 recognition by ELISA and recognition was confirmed by the ability to block the recognition of H2-M3-restricted CTLs.

Suggested Uses

Demonstrated Uses: Immunofluorescence, flow cytometry, ELISA, functional blocking of T cells and immunoprecipitation


Innovation Details
 

File Number: 0838 

Other Information:

References:

Chiu et al. 1999. J. Exp. Med. 190:423

Lybarger et al. 2001. J. Immunol. 167:2097

Wang et al. 2005. J. Virol. 79:4099

Xu et al. 2006. J. Exp. Med. 203:449

 


IP Protection

Copyright: <P style="MARGIN: 0in 0in 0pt">&nbsp;</P>

License Online

This innovation currently is not available for online licensing. Please contact Heather Walsh at University of Chicago for more information.

Request more info via email request more info
People

Case Manager:

Heather Walsh Heather Walsh

Innovations (37)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,783 members 17,070 innovations 152 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...